NESS-0327 See also References Navigation menu104356548611079X1BQI2J97IDTXSID00439851Interactive image(verify)10.1124/jpet.103.0499241266368910.1248/cpb.50.110910.1021/jm800077810.1016/j.ejphar.2005.09.05816271359eexpanding ite

AlkylamidesCaryophylleneCBCCBCVCBDCBDVCBGCBGMCBGVCBLCBDLCBNCBVEpigallocatechin gallateGallocatecholPerrottetineneSerinolamide ATHCTHC-C4THCATHCVYangonin8,11-DiOH-THC11-COOH-THC11-OH-THCA-40174A-41988A-42574Ajulemic acidAM-087AM-411AM-855AM-905AM-906AM-919AM-926AM-938AM-2389AM-4030AMG-1AMG-3AMG-36AMG-41Dexanabinol (HU-211)DMHPDronabinolHHCHU-210HU-243JWH-051JWH-133JWH-139JWH-161JWH-229JWH-359KM-233L-759,633L-759,656Levonantradol (CP 50,5561)MenabitanNabazenilNabidrox (Canbisol)NabiloneNabitanNaboctateO-224O-581O-774O-806O-823O-1057O-1125O-1191O-1238O-2048O-2113O-2365O-2372O-2373O-2383O-2426O-2484O-2545O-2694O-2715O-2716O-3223O-3226ParahexylPirnabineTHC-O-acetateTHC-O-phosphateCannabicyclohexanolCBD-DMHCP 47,497(C6)-CP 47,497(C9)-CP 47,497CP 55,244CP 55,940HU-308HU-320HU-331HU-336HU-345HU-446HU-465HU-910HUF-101NonabineO-1376O-1422O-1601O-1656O-1657O-1660O-1663O-1871SPA-229Tinabinol1-Butyl-3-(2-methoxybenzoyl)indole1-Butyl-3-(4-methoxybenzoyl)indole1-Pentyl-3-(2-methoxybenzoyl)indoleAM-630AM-679AM-694AM-1241AM-2233GW-405,833 (L-768,242)PravadolineRCS-4WIN 54,461AM-1220AM-1221AM-1235AM-2201AM-2232CHM-081EAM-2201FUB-JWH-018JWH-007JWH-015JWH-018JWH-019JWH-073JWH-081JWH-098JWH-116JWH-122JWH-149JWH-164JWH-182JWH-193JWH-198JWH-200JWH-210JWH-398JWH-424MAM-1220MAM-2201NE-CHMIMOTHJ-018THJ-2201WIN 55,212-2JWH-175JWH-176JWH-184JWH-185JWH-192JWH-194JWH-195JWH-196JWH-197JWH-199CannabipiperidiethanoneJWH-167JWH-203JWH-249JWH-250JWH-251JWH-302RCS-85F-ADBICA5F-NNE15F-PCN5F-SDB-006AB-FUBICAAB-PICAADBICAADB-FUBICAAPICACUMYL-BICACUMYL-PICACUMYL-5F-PICAFDU-NNE1MDMB-CHMICAMMB-2201MN-25NNE1PX-1Org 28312Org 28611SDB-006STS-1355F-PB-22FDU-PB-22FUB-PB-22QUCHIC (BB-22)QUPIC (PB-22)NM-22015Br-UR-1445Cl-UR-144A-796,260A-834,735FUB-144UR-144XLR-11XLR-125Cl-APINACA5F-ADB5F-ADB-PINACA5F-AMB5F-APINACA5F-CUMYL-PINACA5F-EMB-PINACAAB-CHMINACAAB-FUBINACAAB-FUBINACA 2-fluorobenzyl isomerAB-PINACAADB-CHMINACAADB-FUBINACAADB-PINACAAdamantyl-THPINACAADSB-FUB-187AMB-CHMINACAAMB-FUBINACAAPINACA (AKB48)APP-FUBINACACUMYL-4CN-BINACACUMYL-PINACACUMYL-THPINACAEMB-FUBINACAFUB-APINACAMDMB-FUBINACAMDMB-CHMINACAMN-18PX-2PX-3FAB-144JWH-030JWH-147JWH-307JWH-369JWH-370AM-883AM-1346ACEAACPAMethanandamide (AM-356)O-585O-689O-1812O-1860O-18615F-AB-FUPPYCAAB-CHFUPYCA4-HTMPIPO5F-PY-PICA5F-PY-PINACA5F-3-pyridinoylindoleA-836,339A-955,840Abnormal cannabidiolAB-001BzODZ-EPyrAM-1248AM-1714AZ-11713908BAY 38-7271BAY 59-3074BIM-018CB-13CB-86CBS-0550CUMYL-4CN-B7AICA5F-CUMYL-P7AICACUMYL-PEGACLONEFUBIMINAGSK-554,418AGW-842,166XJTE 7-31LASSBio-881LBP-1LeelamineMDA-7MDA-19MEPIRAPIMNESS-040C5NMP-7O-889O-1269O-1270O-1399O-1602O-2220OlorinabPF-03550096PSB-SB-1202PTI-1PTI-2QMPSBS-444,823SER-601TedalinabURB-447VSN-16WIN 56,0984-Nonylphenylboronic acidAM-404Arachidonoyl serotoninArvanilBIA 10-2474Biochanin ACAY-10401CAY-10429GenisteinGuineesineIDFPJNJ 1661010JNJ-42165279JZL184JZL195KaempferolLY-2183240MK-4409O-1624O-2093Oleoylethanolamide (OEA)OlvanilPalmitoylethanolamide (PEA)PF-04457845PF-622PF-750PF-3845PHOPURB-447URB-597URB-602URB-754VDM-11


CannabinoidsCB1 receptor antagonistsHydrazidesChloroarenesPyrazolesPiperazinesCannabinoid stubs


antagonistcannabinoid receptorCB1rimonabantKiinverse agonistneutral antagonist





















NESS-0327
NESS-0327.png
Legal status
Legal status


  • CA: Schedule II

Identifiers

PubChem CID
  • 10435654
ChemSpider

  • 8611079 ☒N
UNII
  • X1BQI2J97I

CompTox Dashboard (EPA)
  • DTXSID00439851 Edit this at Wikidata
Chemical and physical data
Formula
C24H23Cl3N4O
Molar mass489.824 g/mol g·mol−1
3D model (JSmol)
  • Interactive image

.mw-parser-output .noboldfont-weight:normal
 ☒N☑Y (what is this?)
  (verify)

NESS-0327 is a drug used in scientific research which acts as an extremely potent and selective antagonist of the cannabinoid receptor CB1. It is much more potent an antagonist, and more selective for the CB1 receptor over CB2, than the more commonly used ligand rimonabant, with a Ki at CB1 of 350fM (i.e. 0.00035nM) and a selectivity of over 60,000x for CB1 over CB2.[1]
Independently, two other groups have described only modest nanomolar CB1 affinity for this compound (125nM[2] and
18.4nM[3]).
Also unlike rimonabant, NESS-0327 does not appear to act as an inverse agonist at higher doses, instead being a purely neutral antagonist which blocks the CB1 receptor but does not produce any physiological effect of its own.[4]



See also


  • Discovery and development of Cannabinoid Receptor 1 Antagonists

  • NESS-040C5


References




  1. ^ Ruiu, S; Pinna, GA; Marchese, G; Mussinu, JM; Saba, P; Tambaro, S; Casti, P; Vargiu, R; Pani, L (Jul 2003). "Synthesis and characterization of NESS 0327: a novel putative antagonist of the CB1 cannabinoid receptor". Journal of Pharmacology and Experimental Therapeutics. 306 (1): 363–70. doi:10.1124/jpet.103.049924. PMID 12663689..mw-parser-output cite.citationfont-style:inherit.mw-parser-output .citation qquotes:"""""""'""'".mw-parser-output .citation .cs1-lock-free abackground:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration abackground:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center.mw-parser-output .citation .cs1-lock-subscription abackground:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registrationcolor:#555.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration spanborder-bottom:1px dotted;cursor:help.mw-parser-output .cs1-ws-icon abackground:url("//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png")no-repeat;background-position:right .1em center.mw-parser-output code.cs1-codecolor:inherit;background:inherit;border:inherit;padding:inherit.mw-parser-output .cs1-hidden-errordisplay:none;font-size:100%.mw-parser-output .cs1-visible-errorfont-size:100%.mw-parser-output .cs1-maintdisplay:none;color:#33aa33;margin-left:0.3em.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-formatfont-size:95%.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-leftpadding-left:0.2em.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-rightpadding-right:0.2em


  2. ^ Stoit, A.R.; Lange, J.H.M.; den Hartog, A.P.; Ronken, E.; Tipker, K.; van Stuivenberg, H.H.; Dijksman, J.A.R.; Wals, H.C.; Kruse, C.G. (2002). "Design, Synthesis and Biological Activity of Rigid Cannabinoid CB1 Receptor Antagonists". Chem. Pharm. Bull. 50 (8): 1109–1113. doi:10.1248/cpb.50.1109.


  3. ^ Zhang, Y.; Burgess, J.P.; Brackeen, M.; Gilliam, A.; Mascarella, S.W.; Page, K.; Seltzman, H.H.; Thomas, B.F. (2008). "Conformationally Constrained Analogues of N -(Piperidinyl)-5-(4-Chlorophenyl)-1-(2,4- Dichlorophenyl)-4-Methyl-1 H -Pyrazole-3-Carboxamide (SR141716): Design, Synthesis, Computational Analysis, And Biological Evaluations". J. Med. Chem. 51 (12): 3526–3539. doi:10.1021/jm8000778.


  4. ^ Tambaro, S; Mongeau, R; Dessi, C; Pani, L; Ruiu, S (Nov 2005). "Modulation of ATP-mediated contractions of the rat vas deferens through presynaptic cannabinoid receptors". European Journal of Pharmacology. 525 (1–3): 150–3. doi:10.1016/j.ejphar.2005.09.058. PMID 16271359.









Cannabinoid stubs, Cannabinoids, CB1 receptor antagonists, Chloroarenes, Hydrazides, Piperazines, PyrazolesUncategorized
-

Popular posts from this blog

Word for a person who has no opinion about whether god existsWord for having a definite opinion while simultaneously withholding judgment?What's the opposite of “newcomer? Is ”veteran" OK?What do you call an “atheist” who might believe in an afterlife?What's a word for someone who wants to voice opinions but not have them challenged?Word for someone who dismisses contrary opinions as irrational?Somone who thinks they are overly special/out of the ordinaryIs there a word, phrase or idiom for “a person who is incapable of thinking about the future”?The belief that a god is human-likeA word for a non-famous person/thing you have heard a lot aboutAdjective for a person who enjoys taking care of their appearance

Image
Reverse string, can I make it faster? How strictly should I take "Candidates must be local"? Are there historical instances of the capital of a colonising country being temporarily or permanently shifted to one of its colonies? Accepted offer letter, position changed Could you please stop shuffling the deck and play already? How to secure an aircraft at a transient parking space? At what distance can a bugbear, holding a reach weapon, with the Polearm Master feat, get their Opportunity Attack? Why was Goose renamed from Chewie for the Captain Marvel film? Is it necessary to separate DC power cables and data cables? Is "history" a male-biased word ("his+story")? Why the color red for the Republican Party What's wrong with this bogus proof? Doesn't allowing a user mode program to access kernel space memory and execute the IN and OUT instructions defeat the purpose of having CPU modes? Can one live in the U.S. and not use a c...
Read more

What was this official D&D 3.5e Lovecraft-flavored rulebook?What was this set of RPG tools called?As a first-time DM should I let my players play complex character classes and roles?Nymph's Kiss and the RelationshipWhat was the name of this Cleric Prestige Class that shapes metal with its bare hands?Are the 3.5e Dragonlance books third party or official works?What's up with the domain Vile Darkness?What was this 80s book about RPGs?What was the name of this Werewolf band?What book had Rituals to “upgrade” animal companions to keep them viable at higher levels?What was this RPG that had rules for player-owned businesses?

Image
Can a Bard use an arcane focus? Indicating multiple different modes of speech (fantasy language or telepathy) The most efficient algorithm to find all possible integer pairs which sum to a given integer A known event to a history junkie How to color a zone in Tikz Simple image editor tool to draw a simple box/rectangle in an existing image Golf game boilerplate Can I use my Chinese passport to enter China after I acquired another citizenship? No idea how to draw this using tikz Is there an Impartial Brexit Deal comparison site? Reply ‘no position’ while the job posting is still there (‘HiWi’ position in Germany) Bob has never been a M before Lifted its hind leg on or lifted its hind leg towards? Can I rely on these GitHub repository files? How do I repair my stair bannister? Pronouncing Homer as in modern Greek What do you call the infoboxes with text and sometimes images on the side of a page we find in textbooks? What will be t...
Read more

2017 IndyCar Series Contents Series news Teams and drivers Schedule Season summary Footnotes References External links Navigation menu"INDYCAR: Initial 2018 bodywork concepts unveiled"the original"IndyCar confirms switch to Performance Friction brakes in 2017""AJ Foyt Racing will switch to Chevy"the original"Carlos Munoz, Conor Daly will drive for AJ Foyt Racing""Zach Veach's Indy 500 Debut Confirmed with Foyt""No mass exodus from Honda after Ganassi switch""Ex-F1 driver Sato joins Andretti Autosport for 2017 IndyCar season""IndyCar's Ryan Hunter-Reay, sponsor DHL paired through 2020""hhgregg and Andretti Autosport announce partnership for key races in 2016""INDYCAR: Rossi re-signs with Andretti"the original"McLaren Formula 1 - Fernando Alonso to race at Indy 500 with McLaren, Honda and Andretti Autosport""Shank will finally take part in Indy 500 with Harvey, Andretti | MotorSportsTalk""Andretti adds Jack Harvey to Indy 500 field""Ganassi switches to Honda power for 2017""INDYCAR: Chilton returns to Ganassi"the original"IndyCar silly season: Who's going where in 2017?""INDYCAR: Kanaan, NTT Data return to Ganassi"the original"Kimball to remain at Ganassi for 2017""Coyne confirms Bourdais for 2017 IndyCar season""Davison to sub for Bourdais in Indy 500"the original"Gutierrez confirmed for Detroit IndyCar debut""Gutierrez returns with Coyne for rest of 2017 season""Vautier to drive for Coyne at Texas"the original"INDYCAR: Coyne confirms Jones for 2017"the original"Pippa Mann returns to Coyne for Indy 500""Karam, Dreyer & Reinbold teaming up again for Indianapolis 500""Pigot to return to Ed Carpenter Racing""Hildebrand confirmed as full-time Ed Carpenter driver""Veach to replace injured Hildebrand at Barber"the originalNew Team Harding Racing Enters Chaves for 101st Indianapolis 500"Juncos Racing Announces Entry in 101st Running of the Indianapolis 500 :: Juncos Racing""Juncos confirms Pigot for Indy 500""Saavedra confirmed in Juncos' second 500 entry"the original"Lazier confirms Indy 500 run after son's USF2000 debut"the original"Claman DeMelo to race for RLLR at Sonoma"the original"Rahal signs Servia and ace engineer for 2017""IndyCar: Aleshin returns with Schmidt"the original"Aleshin replaced by Saavedra for Toronto""Jack Harvey will pilot SPM No. 7 car at Watkins Glen, Sonoma""Jay Howard confirmed in Tony Stewart's supported SPM Indy entry""INDYCAR: Newgarden to wave the flag at Penske"the original"Pagenaud opts for No. 1 in 2017"the original"Penske confirms Newgarden for 2017""Montoya to stay with Team Penske in 2017""Target leaving IndyCar after 27 seasons with Chip Ganassi""Cavin: IndyCar could see complete driver/team shakeup in 2017""End of the road for KV Racing?""KV Racing confirms closure, equipment sold to Juncos""Juncos confirms IndyCar Series entry"the original"Juncos readies IndyCar program, aims for '17 500"the original"Harding Racing to add Texas, Pocono to schedule"the original"Sato signs with Andretti Autosport for 2017""INDYCAR: Aleshin in Doubt at SPM"the original"Long Beach notebook: JR Hildebrand breaks hand""Hildebrand cleared to return at Phoenix"the original"Bourdais to undergo surgery on multiple fractures""Aleshin loses Schmidt Peterson IndyCar ride""Saavedra in at SPM for Pocono, Gateway"the original"Bourdais to make return at Gateway"the original"The IndyCar Grand Prix no longer is sponsored by Angie's List""2017 IndyCar Series rulebook""2017 Verizon IndyCar Series Official Rulebook"Official websiteeeeee

Image
1905190919101911191219131914191519161917191819191920192119221923192419251926192719281929193019311932193319341935193619371938193919401941194619471948194919501951195219531954195519791980198119821983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200819961996–971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019Kenny BräckBuzz CalkinsScott DixonDario FranchittiSam Hornish Jr.Ryan Hunter-ReayTony KanaanBuddy LazierJosef NewgardenSimon PagenaudWill PowerGreg RayScott SharpTony StewartDan WheldonGatewayIndianapolisIowaPoconoTexasBarberCircuit of the AmericasIndianapolisLaguna SecaMid-OhioPortlandRoad AmericaDetroitLong BeachSt. PetersburgTorontoAtlantaBaltimoreCharlotteChicagolandDoverEdmontonFontanaHomesteadHoustonKansasKentuckyLas VegasLouisianaMichiganMilwaukeeMotegiNashvilleNazarethNew HampshirePhoenixPikes PeakRichmondSão PauloSonomaSurfers ParadiseWalt Disney WorldWatkins GlenBostonBras...
Read more